Abstract
Miliary tuberculosis is a potentially lethal type of tuberculosis that results from the hematogenous dissemination of Mycobacterium tuberculosis bacilli. We herein describe the case of a 34-year-old man that presented with a one-month history of cough and fever, while his sputum smear results were negative. Chest computed tomography revealed bilateral centrilobular ground-glass opacification (GGO), suggestive of hypersensitivity pneumonitis; thus, bronchoscopy was performed. Cryobiopsy specimens revealed necrotic granulomas. A re-examination of sputum after bronchoscopy identified Mycobacterium tuberculosis, and miliary tuberculosis was diagnosed. A cryobiopsy might be useful for diagnosing miliary tuberculosis pathologically, particularly when miliary nodules may be masked by GGO.
Keywords: cryobiopsy, forceps biopsy, miliary tuberculosis, hypersensitivity pneumonitis
Introduction
Miliary tuberculosis is the hematogenous dissemination of Mycobacterium tuberculosis bacilli and it is a potentially lethal type of tuberculosis. The findings of miliary tuberculosis on chest computed tomography (CT) show randomly distributed micro-nodules and may be accompanied by ground-glass opacification (GGO) (1). In approximately two-thirds of miliary tuberculosis cases, sputum smear tests are negative (2). Although transbronchial biopsy can be considered in these cases, the diagnostic yields are not high (62.5-76%) (2,3).
Recently, transbronchial cryobiopsy has been widely used for the diagnosis of interstitial lung diseases and tumours (4-7). Cryobiopsy specimens are large, with fewer artefacts and more alveolar tissue histopathologically (8). However, there have so far been few reports on cryobiopsy for diagnosing tuberculosis.
We herein report a case of miliary tuberculosis that mimicked hypersensitivity pneumonitis based on radiological and clinical findings, in which cryobiopsy was useful for the diagnosis.
Case Report
A 34-year-old man was admitted to our hospital because of a persistent cough and fever for one month. CT upon admission at our hospital revealed the diffuse distribution of nodules and diffuse centrilobular GGO (Fig. 1A). The centrilobular GGO made it difficult to interpret the distribution of the nodules. However, there were no prior episodes of antigen exposure suspected of hypersensitivity pneumonitis. The laboratory test results revealed C-reactive protein and lactate dehydrogenase levels of 9.44 mg/dL and 707 U/L, respectively; the Krebs von den Lungen (KL)-6 levels were not elevated. Both the sputum smear test and TB-LAMP (Eiken, Tokyo, Japan) were negative. Although the fever temporarily improved and C-reactive protein decreased to 3.46 mg/dL on Day 2 of admission, the patient's body temperature increased to 38.5 degrees on Day 5.
Figure 1.
A chest computed tomography (CT) scan of the patient before (A) and one month after the initiation of anti-tuberculosis treatment (B). Chest CT performed one month after the initiation of anti-tuberculosis treatment showed the disappearance of the ground-glass opacification and diffuse, randomly distributed nodules.
The centrilobular GGO and temporary clinical improvement after hospitalization suggested hypersensitivity pneumonitis; thus, bronchoscopy was performed on Day 5 of admission. A bronchoalveolar lavage (BAL) fluid analysis revealed an increase in total cell count (6.43×105/mL) and lymphocytes (58.6%). A transbronchial lung biopsy was performed using standard biopsy forceps (FB-20C-1; Olympus, Tokyo, Japan) from the right B2b and B8b, and subsequently using a 1.9-mm cryoprobe (20402-040, Erbe Elektromedizin GmbH, Tubingen, Germany) from the right B8b. Acid-fast bacilli smear and tuberculosis loop-mediated isothermal amplification (TB-LAMP) of BAL fluid yielded negative results. A histological examination of the cryobiopsy specimens revealed necrotic epithelioid cell granulomas predominantly located around the bronchial walls and vessels; most granulomas were larger than those observed in typical hypersensitivity pneumonitis (Fig. 2A, B) (9). These findings are characteristic of mycobacterial infections. Additionally, there was neither findings of angiitis nor fungus histologically. Grocott staining, periodic acid-Schiff reaction, and Ziehl-Neelsen staining results were negative. An examination of forceps biopsy specimens showed granulomatous pneumonitis without any apparent necrotic foci. Moreover, because of an inadequate amount of granulomas in the specimen fragments, the anatomical distribution of the granulomas was unclear (Fig. 2C, D).
Figure 2.
(A) Histological findings of the cryobiopsy specimens revealed numerous granulomas predominantly located around the bronchial walls and vessels (arrows). (B) High-power microscopic view of cryobiopsy specimens revealed necrotic epithelioid cell granuloma in the bronchial wall. (C) (D) Forceps biopsy specimens showed extensive granulomatous pneumonitis, compatible with the ground-glass opacification observed on performing computed tomography (A: Hematoxylin and Eosin (H&E) staining, magnification ×40; B: H&E staining, magnification ×200; C: H&E staining, magnification ×100; D: H&E staining, magnification ×400).
Based on the histopathological findings of a cryobiopsy, miliary tuberculosis was suspected; hence, the sputum was re-examined after bronchoscopy. TB-LAMP of the sputum yielded positive results, and a sputum culture identified the presence of M. tuberculosis. Miliary tuberculosis was diagnosed, and treatment was initiated with isoniazid 300 mg, rifampicin 600 mg, ethambutol 1,000 mg. After one month, chest CT showed the disappearance of GGO and the random distribution of the nodules (Fig. 1B). The patient's clinical state improved after anti-tuberculosis therapy.
Discussion
We herein report a case of miliary tuberculosis mimicking hypersensitivity pneumonitis, in which a cryobiopsy was useful for making the diagnosis.
The temporary improvement after hospitalization (which appeared to be due to antigen avoidance), centrilobular GGO on CT, and BAL fluid lymphocytosis, were suggestive of hypersensitivity pneumonitis (10-12). In our case, it was difficult to recognize the distribution of miliary nodules by CT at the time of admission due to extensive centrilobular GGO. One month after the initiation of treatment, GGO disappeared on CT, and it was clear that the nodules were distributed randomly. The rate of GGO in miliary tuberculosis patients has been reported to be 67% (1). GGO is thought to represent a transient exudative reaction (13), and extensive GGO can make the detection of miliary nodules difficult (1).
Cryobiopsy specimens are typically larger than forceps specimens (8). Therefore, in the present case, it is possible that the large samples of external wall lesions taken using the cryoprobe facilitated the histological diagnosis of miliary tuberculosis with hematogenous distributions. The samples obtained by forceps biopsy were insufficient for the histological diagnosis of tuberculosis because they contained few necrotic epithelioid cell granulomas and the granuloma distribution was not clear.
In our case, a tissue culture was not performed because, before performing the cryobiopsy, we had initially suspected that the patient had hypersensitive pneumonitis. Since M. tuberculosis is not easily killed by cryopreservation (14), freezing with a cryoprobe is not expected to hinder tissue culturing. Additionally, it has been reported that the diagnostic rate of transbronchial cryobiopsy was 100% (16/16) by culture, while the rate was 81.3% (14/16) by GeneXpertⓇ MTB/RIF (Cepheid, Sunnyvale, USA) (15). Hence, we might diagnose M. tuberculosis by a tissue culture; however, the final diagnosis was made on the basis of sputum culture results.
In terms of safety, the major complications after transbronchial cryobiopsy are pneumothorax and bleeding (16); the bleeding risk due to transbronchial cryobiopsy is reportedly higher than that due to transbronchial forceps biopsy (17). Although transbronchial cryobiopsy due to infection, including M. tuberculosis infection, is reportedly relatively safe and the complications are controllable (15,18), it should nevertheless be carefully performed.
It is important to diagnose and treat tuberculosis at an early stage because a misdiagnosis can lead to increased infection transmission. However, there are some cases where it is difficult to demonstrate M. tuberculosis. In such cases, the pathological findings can help in the diagnosis of tuberculosis. Therefore, transbronchial cryobiopsy might be more useful than forceps biopsy, especially for miliary tuberculosis.
In conclusion, we encountered a case of miliary tuberculosis that mimicked hypersensitivity pneumonitis based on radiological and clinical findings; cryobiopsy helped in the diagnosis. Cryobiopsy might therefore be more useful than forceps biopsy for diagnosing miliary tuberculosis pathologically.
The authors state that they have no Conflict of Interest (COI).
References
- 1.Lee J, Lim JK, Seo H, et al. Clinical relevance of ground glass opacity in 105 patients with miliary tuberculosis. Respir Med 108: 924-930, 2014. [DOI] [PubMed] [Google Scholar]
- 2.Maartens G, Willcox PA, Benatar SR. Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults. Am J Med 89: 291-296, 1990. [DOI] [PubMed] [Google Scholar]
- 3.Kim JH, Langston AA, Gallis HA. Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis, and outcome. Rev Infect Dis 12: 583-590, 1990. [DOI] [PubMed] [Google Scholar]
- 4.Ganganah O, Guo SL, Chiniah M, Li YS. Efficacy and safety of cryobiopsy versus forceps biopsy for interstitial lung diseases and lung tumours: a systematic review and meta-analysis. Respirology 21: 834-841, 2016. [DOI] [PubMed] [Google Scholar]
- 5.Hetzel J, Maldonado F, Ravaglia C, et al. Transbronchial cryobiopsies for the diagnosis of diffuse parenchymal lung diseases: expert statement from the cryobiopsy working group on safety and utility and a call for standardization of the procedure. Respiration 95: 188-200, 2018. [DOI] [PubMed] [Google Scholar]
- 6.Hetzel J, Eberhardt R, Herth FJ, et al. Cryobiopsy increases the diagnostic yield of endobronchial biopsy: a multicentre trial. Eur Respir J 39: 685-690, 2012. [DOI] [PubMed] [Google Scholar]
- 7.Schumann C, Hetzel J, Babiak AJ, et al. Cryoprobe biopsy increases the diagnostic yield in endobronchial tumor lesions. J Thorac Cardiovasc Surg 140: 417-421, 2010. [DOI] [PubMed] [Google Scholar]
- 8.Colby TV, Tomassetti S, Cavazza A, Dubini A, Poletti V. Transbronchial cryobiopsy in diffuse lung disease: update for the pathologist. Arch Pathol Lab Med 141: 891-900, 2017. [DOI] [PubMed] [Google Scholar]
- 9. Ohshimo S, Guzman J, Costabel U, Bonella F. Differential diagnosis of granulomatous lung disease: clues and pitfalls: number 4 in the series “Pathology for the clinician”. Dorfmüller P, Cavazza A, Eds. Eur Respir Rev 26: 170012, 2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Schuyler M, Cormier Y. The diagnosis of hypersensitivity pneumonitis. Chest 111: 534-536, 1997. [DOI] [PubMed] [Google Scholar]
- 11.Cormier Y, Lacasse Y. Keys to the diagnosis of hypersensitivity pneumonitis: the role of serum precipitins, lung biopsy, and high-resolution computed tomography. Clin Pulm Med 3: 72-77, 1996. [Google Scholar]
- 12.Hirschmann JV, Pipavath SN, Godwin JD. Hypersensitivity pneumonitis: a historical, clinical, and radiologic review. Radiographics 29: 1921-1938, 2009. [DOI] [PubMed] [Google Scholar]
- 13.Fujita J, Bandoh S, Kubo A, et al. HRCT shows variations in appearance in disseminated tuberculosis in adults. Int J Tuberc Lung Dis 10: 222-226, 2006. [PubMed] [Google Scholar]
- 14.Kim TH, Kubica GP. Long-term preservation and storage of mycobacteria. Appl Microbiol 24: 311-317, 1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sánchez-Cabral O, Santillán-Díaz C, Flores-Bello AP, et al. GeneXpertⓇ MTB/RIF assay with transbronchial lung cryobiopsy for Mycobacterium tuberculosis diagnosis. 8: 351, 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hetzel J, Maldonado F, Ravaglia C, et al. Transbronchial cryobiopsies for the diagnosis of diffuse parenchymal lung diseases: expert statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure. Respiration 95: 188-200, 2018. [DOI] [PubMed] [Google Scholar]
- 17.Hetzel J, Eberhardt R, Petermann C, et al. Bleeding risk of transbronchial cryobiopsy compared to transbronchial forceps biopsy in interstitial lung disease-a prospective, randomized, multicentre cross-over trial. Respir Res 20: 140, 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Sánchez-Cabral O, Martínez-Mendoza D, Fernandez-Bussy S, et al. Utility of transbronchial lung cryobiopsy in non-interstitial diseases. Respiration 94: 285-292, 2017. [DOI] [PubMed] [Google Scholar]


